194 related articles for article (PubMed ID: 27531952)
21. Isoniazid-rifampicin induced lipid changes in rats.
Pal R; Rana SV; Vaiphei K; Singh K
Clin Chim Acta; 2008 Mar; 389(1-2):55-60. PubMed ID: 18157944
[TBL] [Abstract][Full Text] [Related]
22. Reparation of Isoniazid and Rifampicin Combinatorial Therapy-Induced Hepatotoxic Effects by Bacopa monnieri.
Evan Prince S; Udhaya LB; Sunitha PS; Arumugam G
Pharmacology; 2016; 98(1-2):29-34. PubMed ID: 27007136
[TBL] [Abstract][Full Text] [Related]
23. Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits.
Sarich TC; Youssefi M; Zhou T; Adams SP; Wall RA; Wright JM
Arch Toxicol; 1996; 70(12):835-40. PubMed ID: 8911642
[TBL] [Abstract][Full Text] [Related]
24. Acute isoniazid intoxication: seizures, acidosis and coma.
Temmerman W; Dhondt A; Vandewoude K
Acta Clin Belg; 1999 Aug; 54(4):211-6. PubMed ID: 10544512
[TBL] [Abstract][Full Text] [Related]
25. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
[TBL] [Abstract][Full Text] [Related]
26. Metallothionein protects against isoniazid-induced liver injury through the inhibition of CYP2E1-dependent oxidative and nitrosative impairment in mice.
Lian Y; Zhao J; Wang YM; Zhao J; Peng SQ
Food Chem Toxicol; 2017 Apr; 102():32-38. PubMed ID: 28126494
[TBL] [Abstract][Full Text] [Related]
27. Isoniazid toxicity presenting as status epilepticus and severe metabolic acidosis.
Gokhale YA; Vaidya MS; Mehta AD; Rathod NN
J Assoc Physicians India; 2009 Jan; 57():70-1. PubMed ID: 19753763
[TBL] [Abstract][Full Text] [Related]
28. CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid.
Cheng J; Krausz KW; Li F; Ma X; Gonzalez FJ
Toxicol Appl Pharmacol; 2013 Jan; 266(2):245-53. PubMed ID: 23142471
[TBL] [Abstract][Full Text] [Related]
29. The identification of key metabolites and mechanisms during isoniazid/rifampicin-induced neurotoxicity and hepatotoxicity in a mouse model by HPLC-TOF/MS-based untargeted urine metabolomics.
Song Y; Ma J; Gao H; Zhai J; Zhang Y; Gong J; Qu X; Hu T
J Pharm Biomed Anal; 2023 Nov; 236():115709. PubMed ID: 37690188
[TBL] [Abstract][Full Text] [Related]
30. IgG3 is the dominant subtype of anti-isoniazid antibodies in patients with isoniazid-induced liver failure.
Metushi IG; Lee WM; Uetrecht J
Chem Res Toxicol; 2014 May; 27(5):738-40. PubMed ID: 24786179
[TBL] [Abstract][Full Text] [Related]
31. [Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver].
Musch E; Eichelbaum M; Wang JK; von Sassen W; Ochs HR; Castro-Parra M; Dengler HJ
Med Welt; 1982 Jun; 33(25):911-4. PubMed ID: 7109939
[No Abstract] [Full Text] [Related]
32. Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection.
Gray EL; Goldberg HF
Intern Med J; 2016 Mar; 46(3):281-7. PubMed ID: 26648478
[TBL] [Abstract][Full Text] [Related]
33. Isoniazid hepatotoxicity in renal transplant recipients.
Antony SJ; Ynares C; Dummer JS
Clin Transplant; 1997 Feb; 11(1):34-7. PubMed ID: 9067692
[TBL] [Abstract][Full Text] [Related]
34. Toxicoproteomic Profiling of
Brewer CT; Kodali K; Wu J; Shaw TI; Peng J; Chen T
Cells; 2020 Jul; 9(7):. PubMed ID: 32660103
[TBL] [Abstract][Full Text] [Related]
35. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.
Wu SS; Chao CS; Vargas JH; Sharp HL; MartÃn MG; McDiarmid SV; Sinatra FR; Ament ME
Transplantation; 2007 Jul; 84(2):173-9. PubMed ID: 17667808
[TBL] [Abstract][Full Text] [Related]
36. Auto-oxidation of Isoniazid Leads to Isonicotinic-Lysine Adducts on Human Serum Albumin.
Meng X; Maggs JL; Usui T; Whitaker P; French NS; Naisbitt DJ; Park BK
Chem Res Toxicol; 2015 Jan; 28(1):51-8. PubMed ID: 25489718
[TBL] [Abstract][Full Text] [Related]
37. Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats.
Metushi IG; Nakagawa T; Uetrecht J
Chem Res Toxicol; 2012 Nov; 25(11):2567-76. PubMed ID: 23016703
[TBL] [Abstract][Full Text] [Related]
38. Intentional overdosage with isoniazid: case report and review of literature.
Tai DY; Yeo JK; Eng PC; Wang YT
Singapore Med J; 1996 Apr; 37(2):222-5. PubMed ID: 8942271
[TBL] [Abstract][Full Text] [Related]
39. Metabolomic Study to Determine the Mechanism Underlying the Effects of
Ke XH; Wang CG; Luo WZ; Wang J; Li B; Lv JP; Dong RJ; Ge DY; Han Y; Yang YJ; Tu-Erxun RY; Liu HS; Wang YC; Liao Y
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486347
[TBL] [Abstract][Full Text] [Related]
40. Isoniazid accumulation in Mycobacterium smegmatis is modulated by proton motive force-driven and ATP-dependent extrusion systems.
Choudhuri BS; Sen S; Chakrabarti P
Biochem Biophys Res Commun; 1999 Mar; 256(3):682-4. PubMed ID: 10080959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
